SCHEMBL13138664

SCHEMBL13138664

[2H]C([2H])([2H])c1ccc([N+](=O)[O-])cc1N

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 6/20 0.76
CYP3A4 P08684 5/20 0.76
TDP1 Q9NUW8 7/20 0.61
ALDH1A1 P00352 7/20 0.61
GAA P10253 2/20 0.55
THRB P10828 1/20 0.55
HTT P42858 1/20 0.51
ALOX15 P16050 2/20 0.50
MAPT P10636 3/20 0.45
MEN1 O00255 2/20 0.45
GFER P55789 2/20 0.45
KMT2A Q03164 2/20 0.45
ACHE P22303 1/20 0.44
APEX1 P27695 2/20 0.43
KDM4E B2RXH2 1/20 0.43
ATM Q13315 1/20 0.43
POLB P06746 1/20 0.43
CASP6 P55212 1/20 0.43
CTDSP1 Q9GZU7 1/20 0.43
PDE2A O00408 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2313 0.86 CYP3A4 (1.00) TSHRCYP3A4TDP1ALDH1A1GAA
SCHEMBL4437873 0.86 CYP3A4 (1.00) TSHRCYP3A4TDP1ALDH1A1GAA
Water SCHEMBL7777064 0.85 CYP3A4 (0.96) TSHRCYP3A4TDP1ALDH1A1GAA
Hydrochloric Acid SCHEMBL27699078 0.85 CYP3A4 (0.96) TSHRCYP3A4TDP1ALDH1A1GAA
SCHEMBL13138666 0.81 ALDH1A1 (0.59) TSHRCYP3A4TDP1ALDH1A1GAA
SCHEMBL19748062 0.78 ALDH1A1 (0.55) TSHRCYP3A4TDP1ALDH1A1THRB
SCHEMBL78293 0.78 CYP3A4 (0.69) TSHRCYP3A4TDP1ALDH1A1GAA
SCHEMBL29353815 0.78 CYP3A4 (0.69) TSHRCYP3A4TDP1ALDH1A1GAA
Aniline SCHEMBL22169148 0.77 CYP3A4 (0.80) TSHRCYP3A4TDP1ALDH1A1GAA
SCHEMBL85646 0.76 ALDH1A1 (1.00) TSHRCYP3A4TDP1ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100221221-A1 N-PHENYL-2-PYRIMIDINEAMINE DERIVATIVES CONCERT PHARMACEUTICALS INC. (US) 2010-09-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221221-A1 N-PHENYL-2-PYRIMIDINEAMINE DERIVATIVES NME2, NME1, ABL1 TSHR 3305/4885CYP3A4 4118/4885TDP1 177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.